Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria Elena Ferreira is active.

Publication


Featured researches published by Maria Elena Ferreira.


European Journal of Medicinal Chemistry | 2008

Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.

Virginia Roldós; Hector Nakayama; Miriam Rolón; Alina Montero-Torres; Fernando Trucco; Susana Torres; Celeste Vega; Yovanni Marrero-Ponce; Viviana Heguaburu; Alicia Gómez-Barrio; Luis Sanabria; Maria Elena Ferreira; Antonieta Rojas de Arias; Enrique Pandolfi

The synthesis and potent antiprotozoal activity of 14-hydroxylunularin, a natural hydroxybibenzyl bryophyte constituent is reported. 14-hydroxylunularin was highly active in vitro assays against culture and intracellular forms of Leishmania spp. and Trypanosoma. cruzi, in absence of cytotoxicity against mammalian cells. Preliminary structure-activity relationship studies showed that the reported bioactivity depends on hybridization at the carbon-carbon bridge, position and number of free hydroxy group on the aromatic rings. The reported results were also in agreement with the in silico prediction using Non-Stochastic Quadratic Fingerprints-based algorithms. The same compound also showed antiprotozoal activity in Leishmania spp. infected mice by oral and subcutaneous administration routes, with an optimal treatment of a daily subcutaneous administration of 10 mg/kg of body weight for 15 days. This study suggested that 14-hydroxylunularin may be chosen as a new candidate in the development of leishmanicidal therapy.


Journal of Pharmacy and Pharmacology | 2001

Cryptofolione derivatives from Cryptocarya alba fruits

Guillermo Schmeda-Hirschmann; Luis Astudillo; Jaume Bastida; Carles Codina; Antonieta Rojas de Arias; Maria Elena Ferreira; Alba Inchaustti

Cryptofolione (1) and the new cryptofolione derivative 6‐(4,6‐dimethoxy‐8‐phenyl‐octa‐1,7‐dienyl)‐4‐hydroxy‐tetrahydro‐pyran‐2‐one (2) were isolated from the fruits of Cryptocarya alba. The structures were elucidated by spectroscopic methods. Cryptofolione showed activity towards Trypanosoma cruzi trypomastigotes, reducing their number by 77% at 250 μg mL−1. Cryptofolione showed moderate cytotoxicity in both macrophages and T. cruzi amastigotes. It also displayed a mild inhibitory effect on the promastigote form of Leishmania spp. As both cytotoxic and trypanocidal effects are similar, the compound presented little selectivity in our assay models.


Journal of Ethnopharmacology | 2011

Zanthoxylum chiloperone leaves extract: First sustainable Chagas disease treatment

Maria Elena Ferreira; Gerardo Cebrián-Torrejón; Alba Segovia Corrales; Ninfa Vera de Bilbao; Miriam Rolón; Celeste Vega Gomez; Karine Leblanc; Gloria Yaluf; Alicia Schinini; Susana Torres; Elva Serna; Antonieta Rojas de Arias; Erwan Poupon; Alain Fournet

ETHNOPHARMACOLOGICAL RELEVANCE Zanthoxylum chiloperone var. angustifolium Engl. (Rutaceae) stem bark is used traditionally in Paraguay for its antiparasitic properties. Canthin-6-one is main compound isolated from Zanthoxylum chiloperone var angustifolium with broad spectrum antifungal, leishmanicidal and trypanocidal activities. AIM OF THE STUDY The qualitative and quantitative characterization and the isolation of main alkaloidal components of different organs of Zanthoxylum chiloperone are investigated by HPLC-UV-MS. The in vitro biological activity of each extract against trypomastigote and amastigote forms of Trypanosoma cruzi parasites were evaluated, then comparison the in vivo efficacy of the ethanolic leaves extract of Zanthoxylum chiloperone with reference drug, benznidazole, in acute Trypanosoma cruzi infected mice when administered by oral route. We have also evaluated the mutagenic and cytotoxic activity of the main component of Zanthoxylum chiloperone, i.e. canthin-6-one, by mouse bone marrow micronucleus test. MATERIALS AND METHODS The compositions of the ethanol extracts obtained after the maceration process were studied by HPLC-UV-MS methods. The quantitation analysis was performed by external standard method, using a calibration curve constructed utilizing solutions containing different concentrations of the reference samples. The anti-trypomastigote activity was evaluated by the lysis effect on mouse blood trypomastigotes (Y strain Trypanosoma cruzi). The anti-amastigote Trypanosoma cruzi activity was evaluated by a modified colorimetric method with chlorophenol red-β-d-galactopyranoside (CPRG). The cytotoxicity of extracts and compounds was performed on NCTC 929 cells. The in vivo efficacy of the ethanolic leaves extract of Zanthoxylum chiloperone and benznidazole, in acute Trypanosoma cruzi (two different strains) was evaluated in Trypanosoma cruzi infected mice; the drugs were administered by oral route. The mortality rates were recorded and parasitaemias in control and treated mice were determined once weekly for 70 days. The mutagenic and cytotoxic activity of the main component of Zanthoxylum chiloperone, canthin-6-one, by mouse bone marrow micronucleus test. RESULTS Canthin-6-one was the main compound of stem and root bark and 5-methoxy-canthin-6-one in leaves and fruits. The ethanolic leaves extract, canthin-6-one and benznidazole presented, approximately, the same level of in vitro activity against trypomastigote and amastigote forms of Trypanosoma cruzi. We have also evaluated the mutagenic and cytotoxic effects of canthin-6-one by micronucleus test in mice. This test showed any mutagenic and cytotoxic damages. The effects of oral or subcutaneous treatments at 10 mg/kg daily for 2 weeks with the ethanolic extract of leaves of Zanthoxylum chiloperone were examined in Balb/c mice infected acutely with Trypanosoma cruzi (CL or Y strain) and compared with benznidazole at 50 mg/kg for 2 weeks. In these experiments, 70 days after infection, parasitaemia and serological response were significantly reduced with the oral ethanolic extract treatment compared with reference drug. CONCLUSIONS This study have shown the efficacy of the leaves extract of Zanthoxylum chiloperone in reducing Trypanosoma cruzi parasitaemia in vivo assays and could be welcomed by scientific and rural communities of Paraguay because it could help them towards the use of local resources to treat an endemic infection, Chagas disease, affecting 20% of the population of this country.


Phytotherapy Research | 1997

Leishmanicidal and trypanocidal activity of extracts and secondary metabolites from basidiomycetes

Alba Inchausti; Antonieta Rojas de Arias; Susana Torres; Maria Elena Ferreira; Hector Nakayama; Alicia Schinini; Kirsten Lorenzen; Timm Anke; Alain Fournet

Seventeen extracts and seven secondary metabolites isolated from basidiomycetes were tested in medium culture against promastigote forms of Leishmania spp. and bloodstream forms of Trypanosoma cruzi. Extracts from the culture filtrate or mycelium were generally inactive against the parasites except the Zucoagaricus genus mycelium extract which reduced by 47% the number of bloodstream forms. Striatin A, striatin B and podoscyphic acid exhibited in vitro activity at 10, 5 and 100 μg/mL, respectively. One compound showed activity against bloodstream forms of T. cruzi, the sesquiterpenoid naematolin, lysing the parasites by 79%. BALB/c mice infected with L. amazonensis were treated 3 weeks post‐infection with striatin A and striatin B by subcutaneous route for 15 days at 10 mg/kg daily. The reference drug, N‐methylglucamine antimonate, administered by subcutaneous injections at 28 mg Sbv/kg/day for 15 days reduced the parasite burden by 71.2% (p <0.05). Subcutaneous administration of straitin A at 10 mg/kg produced a weak decrease of the parasite burdens in the footpad by 17.6%. The treatment with striatin B had no effect and showed higher toxicity than striatin A.


Tetrahedron | 2001

Studies on quinones. Part 34: The reaction of styrene with activated 1,4-benzoquinones: access to potential antiprotozoal pyranobenzoquinones ☆

Jaime A. Valderrama; David Pessoa-Mahana; Ricardo A. Tapia; Antonieta Rojas de Arias; Hector Nakayama; Susana Torres; Jorge Miret; Maria Elena Ferreira

Abstract Styrene reacts with highly electrophilic monosubstituted 1,4-benzoquinones to provide pyranobenzoquinone and phenanthrene derivatives, depending on the nature of the quinone substituent. The participation of transient Diels–Alder adduct intermediates in these reactions and their thermal-induced rearrangements are discussed. The in vitro antiparasital effects of the pyranobenzoquinones against Trypanosoma cruzi and Leishmania spp. are reported.


International Journal of Antimicrobial Agents | 1997

The effect of bisbenzylisoquinoline alkaloids on Trypanosoma cruzi infections in mice

Alain Fournet; Maria Elena Ferreira; Antonieta Rojas de Arias; Alicia Schinini; Hector Nakayama; Susana Torres; Ramonita Sanabria; Hélène Guinaudeau; Jean Bruneton

Five bisbenzylisoquinoline (BBI) alkaloids, curine, cycleanine, isotet:andrine, limacine and pheanthine were tested for trypanocidal activity in C 3H He mice infected with Y or CL strain of Trypanosoma cruzi. The activity was compared with the baseline drug, benznidazole. Oral treatment was more effective with curine at 10 mg/kg or with cycleanine at 2 mg/kg daily for 10 days in mice infected with Y or CL strain. In these groups, the parasitemias were negative after 5-7 weeks after inoculation and mortality time 50 (MT(50)) was significantly higher than untreated mice. Benznidazole was effective in mice infected with CL strain but not in mice infected with Y strain. The other BBI showed a relative efficacy against both strains. The effect of BBI alkaloids could be due to a blocking of the Ca2+ channel for the regulation of T. cruzi infectivity to invade host cells or their selective immunosuppressive properties.


MedChemComm | 2012

Alkaloids from Rutaceae: activities of canthin-6-one alkaloids and synthetic analogues on glioblastoma stems cells

Gerardo Cebrián-Torrejón; Suzana Assad Kahn; Maria Elena Ferreira; Cécile Thirant; Antonieta Rojas de Arias; Bruno Figadère; Alain Fournet; Hervé Chneiweiss; Erwan Poupon

Interesting selectivities for cancer stem cells versus neuronal stem cells are demonstrated in vitro with analogues of canthin-6-one, an indolic alkaloid isolated from Zanthoxylum chiloperone var. angustifolium (Rutaceae). The implication of the PI3/AKT signalling pathway is also disclosed.


Revista Brasileira De Farmacognosia-brazilian Journal of Pharmacognosy | 2011

The antiplasmodium effects of a traditional South American remedy: Zanthoxylum chiloperone var. angustifolium against chloroquine resistant and chloroquine sensitive strains of Plasmodium falciparum

Gerardo Cebrián-Torrejón; Kevin Spelman; Karine Leblanc; Katalina Muñoz-Durango; Sandra Torijano Gutierrez; Maria Elena Ferreira; Antonieta Rojas de Arias; Bruno Figadère; Alain Fournet; Alexandre Maciuk; Philippe Grellier; Nadja B. Cech; Erwan Poupon

Zanthoxylum chiloperone var. angustifolium Engl., Rutaceae, is used in traditional medicine to treat fungal and protozoal infections in the central area of South America. Considering the increasing resistance of Plasmodium falciparum in malarial ridden areas, we explored the anti-plasmodial effects of three compounds isolated from Z. chiloperone. The pyranocoumarin transavicennol and the canthinone alkaloids, canthin-6-one and 5-methoxycanthin-6-one, were found to have IC50 on chloroquine/mefloquine resistant and sensitive strains of P. falciparum of 0.5-2.7, 2.0-5.3 and 5.1-10.4 ƒEg/mL, respectively. Moreover, the formation of heme adducts by these compounds is described by a novel alternative method based on MS-CID methods. The alkylamide sanshool was also identified, for first time in this plant, in the dichloromethanic and ethanolic extracts and the extracts were found to be notably non-toxic and displayed good anti-plasmodial effects.


Journal of Natural Products | 2012

Antiproliferative activity of trans-avicennol from Zanthoxylum chiloperone var. angustifolium against human cancer stem cells.

Gerardo Cebrián-Torrejón; Suzana Assad Kahn; Nathalie Lagarde; Flavia Castellano; Karine Leblanc; Jordi Rodrigo; Valérie Molinier-Frenkel; Antonieta Rojas de Arias; Maria Elena Ferreira; Cécile Thirant; Alain Fournet; Bruno Figadère; Hervé Chneiweiss; Erwan Poupon

Zanthoxylum chiloperone var. angustifolium root bark was studied with the aim of finding novel molecules able to overcome cancer stem cell chemoresistance. Purification of a methanol-soluble extract resulted in the isolation of a known pyranocoumarin, trans-avicennol (1). Compound 1 demonstrated antiproliferative activity on glioma-initiating cells, whereas it was inactive on human neural stem cells. trans-Avicennol (1) activated the MAPK/ERK pathway and was also evaluated for its ability to inhibit the enzyme indoleamine-2,3-dioxygenase.


Pharmaceutical Biology | 2001

Essential Oils from Zanthoxylum chiloperone and Z. riedelianum Growing in Paraguay

Isabelle Guy; Brigitte Charles; Hélène Guinaudeau; Maria Elena Ferreira; Antonieta Rojas de Arias; Alain Fournet

Essential oils from aerial parts of Zanthoxylum chiloperone var. angustifolium Engl. and Z. riedelianum Engl. have been analyzed by GC/MS. Twenty-four compounds were identified, representing 80% of essential oils. The main components of these essential oils are, respectively, cis -nerolidol (71.0%) and spathulenol (65.2%).

Collaboration


Dive into the Maria Elena Ferreira's collaboration.

Top Co-Authors

Avatar

Antonieta Rojas de Arias

Universidad Nacional de Asunción

View shared research outputs
Top Co-Authors

Avatar

Alicia Schinini

Universidad Nacional de Asunción

View shared research outputs
Top Co-Authors

Avatar

Susana Torres

Universidad Nacional de Asunción

View shared research outputs
Top Co-Authors

Avatar

Hector Nakayama

Universidad Nacional de Asunción

View shared research outputs
Top Co-Authors

Avatar

Ninfa Vera de Bilbao

Universidad Nacional de Asunción

View shared research outputs
Top Co-Authors

Avatar

Erwan Poupon

Université Paris-Saclay

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elva Serna

Universidad Nacional de Asunción

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge